Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2000
10/12/2000WO2000059543A1 Over-coated chewing gum formulations
10/12/2000WO2000059539A1 Method and means for treating post-polio syndrome
10/12/2000WO2000059536A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000WO2000059525A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES
10/12/2000WO2000059515A2 Immunomodulating polymers
10/12/2000WO2000059513A1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1α, 25-DIHYDROXY VITAMIN D¿3?
10/12/2000WO2000059512A1 Formulation comprising testosteron undecanoate and castor oil
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000WO2000059509A1 Phthalazine derivatives for treating inflammatory diseases
10/12/2000WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
10/12/2000WO2000059504A1 Method for the treatment of neurological or neuropsychiatric disorders
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059494A1 Styryl sulfone anticancer agents
10/12/2000WO2000059493A2 Improved dialysis solutions and methods
10/12/2000WO2000059489A2 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
10/12/2000WO2000059486A2 Use of cyp2d6 inhibitors in combination therapies
10/12/2000WO2000059485A2 Pharmaceutical compositions comprising in combination a bisphosphonate and a matrix metalloproteinase inhibitor
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059462A1 Composition for cosmetic and dermatological skin care
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000WO2000035939A3 Connective tissue growth factor fragments and methods and uses thereof
10/12/2000WO2000032803A3 Novel nucleic acid transferring agents, compositions containing them and uses
10/12/2000WO2000027196B1 Use of gm-csf to inhibit development of drug resistance in hiv+ patients
10/12/2000WO2000025722A3 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
10/12/2000WO2000020446A3 Bax-mediated apoptosis modulating reagents and methods
10/12/2000WO2000018918A9 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
10/12/2000WO1999064039A9 Bradykinin antagonists
10/12/2000WO1999041376A8 Retinoblastoma protein complexes and retinoblastoma interacting proteins
10/12/2000WO1999038841A8 Adamantanecarboximidamide derivatives and their use as nmda antagonists
10/12/2000WO1997036919A3 Cytokine designated lerk-8
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000DE10004815A1 Human sodium-phosphate cotransporter Npt2B, useful e.g. for identifying agents for treating hyper- and hypo-phosphatemia, and related nucleic acid
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369871A1 .alpha.-substituted carboxylic acid derivatives
10/12/2000CA2369557A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of gabaa receptors
10/12/2000CA2369549A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives and their use as antidiabetics
10/12/2000CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors
10/12/2000CA2369071A1 Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2368623A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/12/2000CA2368493A1 Lta4 hydrolase inhibitors
10/12/2000CA2368240A1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
10/12/2000CA2368083A1 Derivatives of venlafaxine and methods of preparing and using the same
10/12/2000CA2368017A1 Use of erbb receptor ligands in treating diabetes
10/12/2000CA2367403A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000CA2367104A1 Dsp-7 dual-specificity map kinase phosphatase
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2367052A1 Use of cyp2d6 inhibitors in combination therapies
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366895A1 Immunomodulating polymers
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/12/2000CA2366850A1 Method for the treatment of neurological or neuropsychiatric disorders
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365825A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases
10/12/2000CA2365578A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365421A1 Vesicle associated proteins
10/12/2000CA2365419A1 Novel thiazolobenzoimidazole derivatives
10/12/2000CA2363942A1 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
10/12/2000CA2303702A1 Growth hormone and growth hormone releasing hormone compositions
10/11/2000EP1043333A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
10/11/2000EP1043316A2 Nitroimidazole derivatives as sensitivity enhancers for chemotherapy and radiotherapy
10/11/2000EP1043028A1 Method for preventing/remedying mastitis
10/11/2000EP1043024A2 Chronic myeloid leukemia (cml) therapy
10/11/2000EP1043010A2 Personal cleansing composition
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042470A2 Bone marrow secreted proteins and polynucleotides
10/11/2000EP1042467A1 Non-identical genes and their application in improved molecular adjuvants
10/11/2000EP1042365A1 Compounds and methods for modulating occludin related tissue permeability
10/11/2000EP1042355A1 11beta-halogen-7alpha-substituted estratrienes, method for producing pharmaceutical preparations containing said 11beta-halogen-7alpha-substituted estratrienes and use of the same for producing medicaments
10/11/2000EP1042354A2 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
10/11/2000EP1042353A1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives
10/11/2000EP1042349A1 Using polyamide nucleic acid oligomers to engender a biological response
10/11/2000EP1042346A1 86 human secreted proteins
10/11/2000EP1042343A1 Vegi, an inhibitor of angiogenesis and tumor growth
10/11/2000EP1042342A1 53 human secreted proteins
10/11/2000EP1042334A1 Beta-lactamase and dd-peptidase inhibitors
10/11/2000EP1042329A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical, compositions containing them and use for preparing medicines
10/11/2000EP1042328A1 Sarcodictyin and eleutherobin derivatives useful for stabilising microtubles
10/11/2000EP1042327A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
10/11/2000EP1042323A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them
10/11/2000EP1042320A1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists
10/11/2000EP1042317A1 New pharmaceutically active compounds
10/11/2000EP1042315A1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042307A1 Aminothiazole inhibitors of cyclin dependent kinases
10/11/2000EP1042305A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
10/11/2000EP1042301A1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
10/11/2000EP1042300A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
10/11/2000EP1042298A1 Polycyclic alpha-amino-epsilon-caprolactams and related compounds
10/11/2000EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
10/11/2000EP1042293A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042288A1 Tripeptidyl peptidase inhibitors
10/11/2000EP1042285A1 iso-CBI AND iso-CI ANALOGS OF CC-1065 AND THE DUOCARMYCINS
10/11/2000EP1042280A2 Prodrugs of aspartyl protease inhibitors
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1042278A1 1,3-disubstituted ureas as acat inhibitors, and method of preparing thereof
10/11/2000EP1042276A1 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/11/2000EP1042002A1 Pharmaceutical formulations and processes for their preparation
1 ... 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 ... 1564